KR20240144140A - Kif18a 억제제의 합성 - Google Patents
Kif18a 억제제의 합성 Download PDFInfo
- Publication number
- KR20240144140A KR20240144140A KR1020247024721A KR20247024721A KR20240144140A KR 20240144140 A KR20240144140 A KR 20240144140A KR 1020247024721 A KR1020247024721 A KR 1020247024721A KR 20247024721 A KR20247024721 A KR 20247024721A KR 20240144140 A KR20240144140 A KR 20240144140A
- Authority
- KR
- South Korea
- Prior art keywords
- compound
- solvent
- alkyl
- acid
- benzyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C313/00—Sulfinic acids; Sulfenic acids; Halides, esters or anhydrides thereof; Amides of sulfinic or sulfenic acids, i.e. compounds having singly-bound oxygen atoms of sulfinic or sulfenic groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C313/02—Sulfinic acids; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/10—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms
- C07D211/14—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms with hydrocarbon or substituted hydrocarbon radicals attached to the ring nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
- C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
- C07D221/20—Spiro-condensed ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F3/00—Compounds containing elements of Groups 2 or 12 of the Periodic Table
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Steroid Compounds (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Silver Salt Photography Or Processing Solution Therefor (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202263303470P | 2022-01-26 | 2022-01-26 | |
| US63/303,470 | 2022-01-26 | ||
| PCT/US2023/011636 WO2023146973A1 (en) | 2022-01-26 | 2023-01-26 | Synthesis of a kif18a inhibitor |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| KR20240144140A true KR20240144140A (ko) | 2024-10-02 |
Family
ID=85328813
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR1020247024721A Pending KR20240144140A (ko) | 2022-01-26 | 2023-01-26 | Kif18a 억제제의 합성 |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20250129050A1 (https=) |
| EP (1) | EP4469437A1 (https=) |
| JP (1) | JP2025505892A (https=) |
| KR (1) | KR20240144140A (https=) |
| CN (1) | CN118922406A (https=) |
| AR (1) | AR128353A1 (https=) |
| AU (1) | AU2023211589A1 (https=) |
| CA (1) | CA3248925A1 (https=) |
| IL (1) | IL314221A (https=) |
| MX (1) | MX2024009163A (https=) |
| TW (1) | TW202342451A (https=) |
| WO (1) | WO2023146973A1 (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MA54543A (fr) | 2018-12-20 | 2022-03-30 | Amgen Inc | Inhibiteurs de kif18a |
| TW202416973A (zh) | 2022-08-18 | 2024-05-01 | 美商雅客森醫療公司 | Kif18a抑制劑及其用途 |
| CN115925589A (zh) * | 2022-12-26 | 2023-04-07 | 诚达药业股份有限公司 | 一种脂肪族亚磺酸钙盐及其制备方法 |
| WO2025036479A1 (zh) * | 2023-08-16 | 2025-02-20 | 上海湃隆生物科技有限公司 | 驱动蛋白kif18a抑制剂及其应用 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MA54543A (fr) * | 2018-12-20 | 2022-03-30 | Amgen Inc | Inhibiteurs de kif18a |
| MX2022012992A (es) * | 2020-04-14 | 2022-11-08 | Amgen Inc | Inhibidores de kif18a para el tratamiento de enfermedades neoplasicas. |
-
2023
- 2023-01-26 IL IL314221A patent/IL314221A/en unknown
- 2023-01-26 WO PCT/US2023/011636 patent/WO2023146973A1/en not_active Ceased
- 2023-01-26 CA CA3248925A patent/CA3248925A1/en active Pending
- 2023-01-26 US US18/832,887 patent/US20250129050A1/en active Pending
- 2023-01-26 EP EP23706921.6A patent/EP4469437A1/en active Pending
- 2023-01-26 AU AU2023211589A patent/AU2023211589A1/en active Pending
- 2023-01-26 CN CN202380018655.9A patent/CN118922406A/zh active Pending
- 2023-01-26 JP JP2024543870A patent/JP2025505892A/ja active Pending
- 2023-01-26 KR KR1020247024721A patent/KR20240144140A/ko active Pending
- 2023-01-26 MX MX2024009163A patent/MX2024009163A/es unknown
- 2023-01-26 AR ARP230100178A patent/AR128353A1/es unknown
- 2023-01-30 TW TW112103047A patent/TW202342451A/zh unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CN118922406A (zh) | 2024-11-08 |
| CA3248925A1 (en) | 2023-08-03 |
| JP2025505892A (ja) | 2025-03-03 |
| TW202342451A (zh) | 2023-11-01 |
| MX2024009163A (es) | 2024-08-09 |
| AR128353A1 (es) | 2024-04-24 |
| EP4469437A1 (en) | 2024-12-04 |
| WO2023146973A1 (en) | 2023-08-03 |
| IL314221A (en) | 2024-09-01 |
| US20250129050A1 (en) | 2025-04-24 |
| AU2023211589A1 (en) | 2024-07-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR20240144140A (ko) | Kif18a 억제제의 합성 | |
| TWI475992B (zh) | 製備4-{4-[({[4-氯-3-(三氯甲基)-苯基]胺基}羰基)胺基]-3-氟苯氧基}-n-甲基吡啶-2-甲醯胺、其鹽及單水合物之方法 | |
| JP7157752B2 (ja) | Ag-10、その中間体及びその塩の調製方法 | |
| CN102143964A (zh) | 制备腺嘌呤化合物的方法 | |
| KR20160072127A (ko) | Pde4 억제제의 제조 방법 | |
| AU2020267299A1 (en) | Methods of making protein deacetylase inhibitors | |
| TW201738236A (zh) | 一種製備酪胺酸激酶抑制劑及其衍生物的方法 | |
| BRPI0715831A2 (pt) | processo para produÇço da 1-(3,4-diclorobenzil)-5-octilbiguanida ou um sal da mesma | |
| EP4063351A1 (en) | Preparation method of quinoline derivative compounds | |
| EP3348554B1 (en) | Method for producing triazole compound | |
| RU2466983C2 (ru) | Способ синтеза сульфонилгалогенидов и сульфонамидов из солей сульфоновых кислот | |
| EA052216B1 (ru) | Синтез ингибитора kif18a | |
| CN111100111B (zh) | 一种制备苯并噻吩衍生物的方法 | |
| AU2010299484A1 (en) | Polymorphs of sorafenib acid addition salts | |
| IL93393A (en) | Process for the preparation of omicron-carboxypyridyl and omicron-carboxyquinolyl- imidazolinones | |
| KR20160056230A (ko) | 블로난세린의 제조방법 및 그를 위한 중간체 | |
| US10011567B1 (en) | Method for the synthesis of acrylate derivatives | |
| KR101278359B1 (ko) | Npyy5 수용체 길항 작용을 갖는 화합물의 제조 방법 및 유용한 결정 | |
| JPH0350748B2 (https=) | ||
| KR20140027921A (ko) | 디(아릴아미노)아릴 화합물의 제조 방법 및 그 합성 중간체 | |
| CN110914250B (zh) | 用于合成非罗考昔的新工艺 | |
| IT202300023508A1 (it) | Processo per la preparazione della forma polimorfa iii di tapinarof | |
| DK163660B (da) | Fremgangsmaade til fremstilling af benzylalkoholderivater eller farmaceutisk acceptable syreadditionssalte deraf | |
| KR20060070566A (ko) | 디페닐 에테르 화합물의 신규 제조방법 | |
| EA050035B1 (ru) | Способы получения ag-10, его промежуточных соединений и их солей |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PA0105 | International application |
St.27 status event code: A-0-1-A10-A15-nap-PA0105 |
|
| P11-X000 | Amendment of application requested |
St.27 status event code: A-2-2-P10-P11-nap-X000 |
|
| P13-X000 | Application amended |
St.27 status event code: A-2-2-P10-P13-nap-X000 |
|
| PG1501 | Laying open of application |
St.27 status event code: A-1-1-Q10-Q12-nap-PG1501 |
|
| E13 | Pre-grant limitation requested |
Free format text: ST27 STATUS EVENT CODE: A-2-3-E10-E13-LIM-X000 (AS PROVIDED BY THE NATIONAL OFFICE) |
|
| E13-X000 | Pre-grant limitation requested |
St.27 status event code: A-2-3-E10-E13-lim-X000 |
|
| P11 | Amendment of application requested |
Free format text: ST27 STATUS EVENT CODE: A-2-2-P10-P11-NAP-X000 (AS PROVIDED BY THE NATIONAL OFFICE) |
|
| P11-X000 | Amendment of application requested |
St.27 status event code: A-2-2-P10-P11-nap-X000 |